Cibus (CBUS) Other Operating Expenses (2016 - 2025)
Cibus (CBUS) posted Other Operating Expenses of $9.1 million for Q4 2025, down 56.49% sequentially from $21.0 million in Q1 2025.
Cibus (CBUS) Other Operating Expenses (2016 - 2025) Analysis & Trends
Cibus has reported Other Operating Expenses for 10 years, with the latest figure at $9.1 million in Q4 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to $9.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.1 million (down 83.43% YoY) and the FY2025 annual result came in at $30.1 million, down 83.43% from the prior year.
- Other Operating Expenses eased to $9.1 million in Q4 2025 per CBUS's latest filing, from $21.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $249.4 million in Q4 2023 and troughed at -$239000.0 in Q1 2022.
- A 5-year average of $66.4 million and a median of $9.1 million in 2025 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2021 and 2022: Other Operating Expenses slipped 19.58% in 2021, then slumped 896.67% in 2022.
- Over 5 years, Other Operating Expenses stood at $3.8 million in 2021, then tumbled by 106.31% to -$239000.0 in 2022, then surged by 104459.41% to $249.4 million in 2023, then retreated by 27.26% to $181.4 million in 2024, then sank by 94.98% to $9.1 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $9.1 million, $21.0 million, and $181.4 million for Q4 2025, Q1 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.12 Mn |
| Mar 31, 2025 | 20.95 Mn |
| Sep 30, 2024 | 181.43 Mn |
| Dec 31, 2023 | 249.42 Mn |
| Mar 31, 2022 | -239,000.00 |
| Dec 31, 2021 | 3.79 Mn |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 4.71 Mn |
| Sep 30, 2020 | 504,000.00 |
| Jun 30, 2020 | 42,000.00 |
| Mar 31, 2020 | 62,000.00 |
| Dec 31, 2019 | -3.14 Mn |
| Sep 30, 2019 | 1.62 Mn |
| Jun 30, 2019 | 1.65 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 10.69 Mn |
| Sep 30, 2018 | 975,000.00 |
| Jun 30, 2018 | 399,000.00 |
| Mar 31, 2018 | 583,000.00 |
| Dec 31, 2017 | -522,000.00 |